Alopecia Areata
January 2026
in “
Updates in clinical dermatology
”
Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Research cited in this study 43
- Efficacy and Safety of Deuruxolitinib, an Oral Selective Janus Kinase 1/2 Inhibitor, in Adults with Alopecia Areata: Results from the THRIVE-AA2 Phase 3, Randomized, Double-Blind, Controlled Trial
- Efficacy and Safety of Ritlecitinib in Adults and Adolescents With Alopecia Areata: A Randomised, Double-Blind, Multicentre, Phase 2b–3 Trial
- Hair Follicle Immune Privilege and Its Collapse in Alopecia Areata
- Efficacy of Antihistamines in Combination with Topical Corticosteroid and Superficial Cryotherapy for Treatment of Alopecia Areata: A Retrospective Cohort Study
- A Hair-Raising History of Alopecia Areata
- Alopecia Areata: A Long-Term Follow-Up Study of 104 Patients
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- Increased Prevalence of Vitamin D Deficiency in Patients with Alopecia Areata: A Systematic Review and Meta-Analysis
- Cancer Risk in Patients with Alopecia Areata: A Nationwide Population-Based Matched Cohort Study
- Trichoscopy of Alopecia Areata: An Update
- Immune Privilege Collapse And Alopecia Development: Is Stress A Factor
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Alopecia Areata: Treatment Options and Efficacy
- Evaluation of the Relationship Between Alopecia Areata and Viral Antigen Exposure
- T-Cell Induced-Self MHC Class I/Peptide Complexes May Enable De Novo Tolerance Induction to Neo-Antigens Occurring Outside of the Thymus
- Health-Related Quality of Life Among Patients With Alopecia Areata: A Systematic Review
- Alopecia Areata and Health-Related Quality of Life: A Systematic Review and Meta-Analysis
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Efficacy and Safety of Diphenylcyclopropenone Alone or in Combination with Anthralin in the Treatment of Chronic Extensive Alopecia Areata: A Retrospective Case Series
- Macrophages Contribute to the Cyclic Activation of Adult Hair Follicle Stem Cells
- Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition
- Evaluation and Diagnosis of the Hair Loss Patient
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Trichoscopy in Alopecias: Diagnosis Simplified
- Alopecia Areata Update
- Alopecia Areata: An Autoimmune Disease Causing Hair Loss
- Transcriptional Profiling in Alopecia Areata Defines Immune and Cell Cycle Control Related Genes Within Disease-Specific Signatures
- Genome-Wide Association Study in Alopecia Areata Implicates Both Innate and Adaptive Immunity
- Alopecia Areata Update
- Maintenance of Hair Follicle Immune Privilege Is Linked to Prevention of NK Cell Attack
- Probing the Effects of Stress Mediators on the Human Hair Follicle
- A Comparison of the Efficacy, Relapse Rate, and Side Effects Among Three Modalities of Systemic Corticosteroid Therapy for Alopecia Areata
- Placebo-Controlled Oral Pulse Prednisolone Therapy in Alopecia Areata
- The Pattern and Profile of Alopecia Areata in Singapore: A Study of 219 Asians
- Twice Weekly 5 mg Dexamethasone Oral Pulse in the Treatment of Extensive Alopecia Areata
- The Anagen Hair Cycle Induces Systemic Immunosuppression of Contact Hypersensitivity in Mice
- Eosinophils in Fibrous Tracts and Near Hair Bulbs: A Helpful Diagnostic Feature of Alopecia Areata
- Hair Cycle-Dependent Changes in Skin Immune Functions: Anagen-Associated Depression of Sensitization for Contact Hypersensitivity in Mice
- Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata
- Juvenile Versus Maturity-Onset Alopecia Areata: A Comparative Retrospective Clinical Study
- Double-Blind, Placebo-Controlled Evaluation of Topical Minoxidil in Extensive Alopecia Areata